Moreover, CSF sTREM2 levels fluctuate as AD progresses; Aβ pathology leads to decreased sTREM2 levels, while increases in sTREM2 are associated with Tau deposition (Ma et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.